{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-072678","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.088211+00:00","generated_at":"2026-05-17T22:26:31.292459+00:00","sec_items":["1.01","2.03","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Orchestra BioMed secures up to $67M in financing from Ligand & Medtronic; cash ~$33.9M","bullets":["Ligand pays $35M for tiered revenue rights on BACKBEAT & Virtue SAB products; also buys $5M stock and gets 2M-share warrant.","Medtronic provides $20M convertible loan at 11% interest, plus up to $12M equity purchase in subsequent offering.","Hercules loan amended: amortization delayed, borrowing capacity increased by $15M; warrant terms modified.","Preliminary June 30 cash $33.9M; Terumo mediation expected to complete in Q3 2025.","BACKBEAT study enrollment now expected mid-2026; FDA-approved amendments to expand patient eligibility."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-072678","json":"https://secwatch.observer/filing/0001104659-25-072678.json","markdown":"https://secwatch.observer/filing/0001104659-25-072678.md","text":"https://secwatch.observer/filing/0001104659-25-072678.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925072678/0001104659-25-072678-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925072678/tm2522158d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:26:31.292459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}